INNOVATION MODELS IN THE BIOPHARMACEUTICAL SECTOR - Innovation in the Biopharmaceutical Industry - page 28

Pammolli, F, L Orsenigo, M Riccaboni, M Mariani, A Gambardella, A Bonaccorsai and
A Allansdottir (2002). Innovation and Competitiveness in European Biotechnology .
Enterprise Paper No. 7. Brussels: Enterprise Directorate-General, European Commis-
sion. Available at URL: www.europa.eu.int.
Pammolli, F, M Riccaboni and L Magazzini (2003). The dynamics of competition in phar-
maceuticals: on patent expiry, generic penetration and industry structure. 4th iHEA
World Congress , San Francisco, USA, 15-18 June.
Parker, JES (1984). The International Diffusion of Pharmaceuticals . New York: St Martins
Press.
Patel, P (1995). The localised production of global technology. Cambridge Journal of Eco-
nomics , 19, 141-153.
Patel, P and K Pavitt (1994). National innovation systems: why they are important, and how
they might be measured and compared. Economics of Innovation and New Technology ,
3, 77-95.
Pavitt, K (1990). What we know about the strategic management of technology. California
Management Review , 32(3).
Payer, L (1989). Medicine and Culture — Notions of Health and Sickness in Britain, the
US, France and West Germany . London: Victor Gollanz Ltd.
Perez, C (1985). Microelectronics, long waves and world structural change. World Devel-
opment , 13, 441.
Pisano, GP (2006). Science Business: The Promise, the Reality and the Future of Biotech .
Cambridge, MA, USA: Harvard Business School Press.
Porter, M (1990). The Competitive Advantage of Nations . London: Macmillan.
PriceWaterhouseCoopers (2004). Economische analyse van het 'Plan Hoogervorst'.' Ein-
drapport 02 18, p. 64.
Robb R (2006). Europes venture capital institutions are good enough. Paper presented
at CESIFO Conference on 'Perspectives on the performance of the continents'
economies. San Servolo, Venice, 21-22 July.
Rogers, EM (1962). Diffusion of Innovations . New York: Free Press.
Rothearmel, FT (2001).Complementary assets, strategic alliances and the incumbents
advantage: an empirical study of industry and firm effects in the biopharmaceutical
industry. Research Policy , 30, 1235-1251.
Rothearmel, FT and DL Deeds (2004). Exploration and exploitation alliances in biotech-
nology: a system of new product development. Strategic Management Journal , 25,
201-221.
Rothwell, R (1992a). Successful industrial innovation; critical factors for the 1990's. R&D
Management , 22, 221.
Rothwell, R (1992). Industrial innovation and government regulation. Technovation , 12,
447.
Rothwell, R (1984). The role of small firms in the emergence of new technologies. Omega ,
12, 19.
Schmidt, GM (2004). Low-end and high-end encroachments for new products. International
Journal of Innovation Management , 8(2), 167-192.